van Wyk J, Ajana F, Bisshop F, De Wit S, et al. Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose Two-Drug Regimen Versus Continuing a Tenofovir Alafenamide-Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1: Phase 3, Randomized, Non Clin Infect Dis 2020 Jan 6. pii: 5697294. doi: 10.1093/cid/ciz1243.
PMID: 31905383